Technical Analysis for EDAP - EDAP TMS S.A.

Grade Last Price % Change Price Change
F 2.86 -1.38% -0.04
EDAP closed down 1.38 percent on Friday, November 1, 2024, on 30 percent of normal volume. It ran into resistance at its 50 day moving average.
Earnings due: Nov 7
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Stochastic Sell Signal Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Down 3 Days in a Row Weakness 0.00%
Fell Below 50 DMA Bearish -1.38%
New Downtrend Bearish -1.38%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 16 hours ago
Down 2 % about 16 hours ago
Down 1% about 16 hours ago
Reversed from Up about 16 hours ago
Possible Inside Day about 16 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

EDAP TMS S.A. Description

EDAP TMS S.A., through its subsidiaries, engages in the development, production, marketing, distribution, and maintenance of minimally invasive medical devices for the treatment of urological diseases. The company operates in two divisions, High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division offers medical devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. This division provides Ablatherm, a HIFU-based ultrasound guided device for the treatment of organ-confined prostate cancer. Its HIFU technology allows the surgeon to destroy a defined area of diseased tissue without damaging surrounding tissue and organs. This division also engages in the leasing of equipment, as well as the sale of disposables, spare parts, and maintenance services. It markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. The UDS division provides medical devices for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones and other clinical indications. This division manufactures lithotripters, including the Sonolith i-move and the Sonolith i-sys, for the treatment of urinary tract stones by means of ESWL technology. It is also involved in the leasing of lithotripters, as well as the sale of disposables, spare parts, and maintenance services. This division markets and sells its products through its direct sales and service platform, as well as through agents and third-party distributors. The company's customers include public and private hospitals, urology clinics, and research institutions worldwide. EDAP TMS S.A. was founded in 1979 and is based in Vaulx-en-Velin, France.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinic Prostate Cancer Urology Direct Marketing Ultrasound Magnetic Resonance Imaging Urological Disorders Organs Lath Medical Ultrasonography High Intensity Focused Ultrasound Invasive Medical Devices Localized Tumors Minimally Invasive Medical Devices Urological Diseases

Is EDAP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.5
52 Week Low 2.27
Average Volume 78,921
200-Day Moving Average 5.34
50-Day Moving Average 2.93
20-Day Moving Average 2.72
10-Day Moving Average 2.77
Average True Range 0.20
RSI (14) 50.98
ADX 27.03
+DI 21.37
-DI 22.80
Chandelier Exit (Long, 3 ATRs) 2.49
Chandelier Exit (Short, 3 ATRs) 2.86
Upper Bollinger Bands 3.01
Lower Bollinger Band 2.43
Percent B (%b) 0.74
BandWidth 21.38
MACD Line -0.03
MACD Signal Line -0.09
MACD Histogram 0.0611
Fundamentals Value
Market Cap 105.61 Million
Num Shares 36.9 Million
EPS -0.65
Price-to-Earnings (P/E) Ratio -4.40
Price-to-Sales 4.18
Price-to-Book 3.62
PEG Ratio 90.47
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.07
Resistance 3 (R3) 3.08 3.03 3.04
Resistance 2 (R2) 3.03 2.97 3.02 3.02
Resistance 1 (R1) 2.94 2.94 2.92 2.93 3.01
Pivot Point 2.89 2.89 2.87 2.88 2.89
Support 1 (S1) 2.80 2.83 2.78 2.79 2.71
Support 2 (S2) 2.75 2.80 2.74 2.70
Support 3 (S3) 2.66 2.75 2.69
Support 4 (S4) 2.65